Dynavax Technologies Corporation (DVAX): Price and Financial Metrics

Dynavax Technologies Corporation (DVAX)

Today's Latest Price: $4.18 USD

0.02 (0.48%)

Updated Oct 26 9:04am

Add DVAX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 384 in Biotech

See all "A" rated Strong Buy stocks

DVAX Stock Summary

  • With a price/sales ratio of 13.15, Dynavax Technologies Corp has a higher such ratio than 89.07% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 9.94 for Dynavax Technologies Corp; that's greater than it is for 92.41% of US stocks.
  • Revenue growth over the past 12 months for Dynavax Technologies Corp comes in at 66.56%, a number that bests 92.13% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to Dynavax Technologies Corp, a group of peers worth examining would be KALA, PCRX, VIVE, GEVO, and RDFN.
  • DVAX's SEC filings can be seen here. And to visit Dynavax Technologies Corp's official web site, go to www.dynavax.com.

DVAX Stock Price Chart Interactive Chart >

Price chart for DVAX

DVAX Price/Volume Stats

Current price $4.18 52-week high $12.44
Prev. close $4.16 52-week low $1.80
Day low $4.18 Volume 48,649
Day high $4.18 Avg. volume 4,185,255
50-day MA $5.09 Dividend yield N/A
200-day MA $5.51 Market Cap 457.76M

Dynavax Technologies Corporation (DVAX) Company Bio

Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company, using TLR biology to discover and develop novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. The company was founded in 1996 and is based in Berkeley, California.

DVAX Latest News Stream

Event/Time News Detail
Loading, please wait...

DVAX Latest Social Stream

Loading social stream, please wait...

View Full DVAX Social Stream

Latest DVAX News From Around the Web

Below are the latest news stories about Dynavax Technologies Corp that investors may wish to consider to help them evaluate DVAX as an investment opportunity.

Dynavax: Expect Share Price Gains When Heplisav Sales Get Back On Track

Opportunity Overview I last covered Dynavax (DVAX) back in late April, when the company traded at $4.25, and although I labelled it a risky opportunity at the time, I was optimistic about the company and its new management team's chances of bringing its first commercialised product, the recombinant vaccine and...

Edmund Ingham on Seeking Alpha | September 14, 2020

Dynavax inks adjuvanted COVID-19 vaccine supply deal with Valneva

Dynavax Technologies (DVAX) and Valneva (INRLF) announce a commercial partnership for the supply of Dynavax's CpG 1018 adjuvant for use in Valneva's SARS-CoV-2 vaccine candidate, VLA2001.DVAX will supply CpG 1018 to produce up to 100M doses of vaccine in 2021. Valneva has the option to purchase up to an additional 90M doses through...

Seeking Alpha | September 14, 2020

Thinking about buying stock in Cassava Sciences, Mersana Therapeutics, Sorrento Therapeutics, Dynavax Technologies, or Co-Diagnostics?

NEW YORK, Sept. 14, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SAVA, MRSN, SRNE, DVAX, and CODX. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding…

PR Newswire | September 14, 2020

Worldwide Cancer Vaccines Industry to 2027 - Featuring Advaxis, Amgen & Dynavax Technologies Among Others

DUBLIN, Sept. 8, 2020 /PRNewswire/ -- The "Cancer Vaccines Market by Technology, Type, Indication and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering. The global cancer vaccines market was valued at $4,188…

PR Newswire | September 8, 2020

Dynavax Technologies shares are trading higher after the company announced it will sell its SD-101 oncology program to TriSalus Life Sciences in a purchase agreement for up to $250 million in milestone payments plus royalties on future net sales.

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of …

Benzinga | August 3, 2020

Read More 'DVAX' Stories Here

DVAX Price Returns

1-mo -6.70%
3-mo -51.45%
6-mo 0.72%
1-year -16.57%
3-year -80.74%
5-year -81.50%
YTD -26.92%
2019 -37.49%
2018 -51.07%
2017 373.42%
2016 -83.65%
2015 43.30%

Continue Researching DVAX

Want to see what other sources are saying about Dynavax Technologies Corp's financials and stock price? Try the links below:

Dynavax Technologies Corp (DVAX) Stock Price | Nasdaq
Dynavax Technologies Corp (DVAX) Stock Quote, History and News - Yahoo Finance
Dynavax Technologies Corp (DVAX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7919 seconds.